ECDC country visit to Norway to discuss antimicrobial resistance issues

Mission report
Citation Link

European Centre for Disease Prevention and Control. ECDC country visit to Norway to discuss
antimicrobial issues 12–16 March 2018. Stockholm: ECDC; 2019.

Copy citation to clipboard

An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.

Executive summary

Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show that the proportion of AMR in bacteria from bloodstream infections in Norwegian patients is consistently below the EU/EEA average and often among the lowest in Europe. Nevertheless, although considerably below the EU/EEA average, resistance to broad-spectrum antibiotics such as third-generation cephalosporins has been increasing over the past 10 years. This is the result of  emergence of strains that produce an extended-spectrum beta-lactamase (ESBL), combined with increasing consumption of broad-spectrum antibiotics in healthcare.

All updates on antimicrobial resistance and consumption


Less and more appropriate antibiotic use needed to reduce antibiotic resistance

Press release -


Rapid risk assessment: Increase in OXA-244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update

Risk assessment -


EARS-Net Reporting protocol 2021

Tool -


New study by WHO Europe and ECDC examines variations in antibiotic consumption in European countries between 2014 and 2018

News story -


Use of antibiotics in animals is decreasing

Press release -